Equity
Total Equity
Moderna Total Equity decreased by 14.4% to $7.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.4%, from $10.07B to $7.41B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 27.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026May 1, 2026
How to read this metric
An increasing trend indicates value creation through retained earnings or capital raises, while a decrease may signal losses or share buybacks.
Detailed definition
This represents the residual interest in the assets of the company after deducting all liabilities. It is the net book v...
Peer comparison
Standardized metric used to calculate Return on Equity (ROE) and book value per share.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.7B | $10.12B | $14.15B | $17.08B | $17.99B | $17.99B | $19.12B | $18.86B | $16.95B | $13.46B | $13.85B | $12.82B | $11.71B | $11.93B | $10.9B | $10.07B | $9.4B | $9.33B | $8.65B | $7.41B |
| QoQ Change | — | +51.0% | +39.7% | +20.7% | +5.3% | +0.0% | +6.3% | -1.4% | -10.1% | -20.6% | +3.0% | -7.5% | -8.6% | +1.8% | -8.6% | -7.7% | -6.6% | -0.7% | -7.3% | -14.4% |
| YoY Change | — | — | — | — | +168.3% | +77.7% | +35.2% | +10.5% | -5.8% | -25.2% | -27.6% | -32.1% | -30.9% | -11.4% | -21.3% | -21.5% | -19.7% | -21.8% | -20.6% | -26.4% |
Range$6.7B – $19.12B
CAGR+2.1%
Avg YoY Growth+1.7%
Median YoY Growth-21.0%
Current Streak6 quarters decline
Total Equity at Other Companies
Frequently Asked Questions
- What is Moderna's total equity?
- Moderna (MRNA) reported total equity of $7.41B in Q1 2026.
- How has Moderna's total equity changed year-over-year?
- Moderna's total equity decreased by 26.4% year-over-year, from $10.07B to $7.41B.
- What is the long-term trend for Moderna's total equity?
- Over 5 years (2020 to 2025), Moderna's total equity has grown at a 27.6% compound annual growth rate (CAGR), from $2.56B to $8.65B.
- What does total equity mean?
- The total value of the company belonging to shareholders after all debts are paid.